Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment (Q46165410)

20 December 2017

http://europepmc.org/abstract/MED/19140214

title

Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment (English)

1 reference

20 December 2017

http://europepmc.org/abstract/MED/19140214

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

author name string

Maria Edilenza F Brito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

Marina A Souza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

Angela C R Medeiros

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

Claudio J Silva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

Carlos F Luna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

Valéria R A Pereira

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

publication date

1 January 2009

1 reference

20 December 2017

http://europepmc.org/abstract/MED/19140214

published in

Journal of Clinical Laboratory Analysis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

page(s)

63-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

Cell mediated immunity in American cutaneous and mucosal leishmaniasis

15 May 2020

cites work

1 reference

12 December 2020

Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers.

1 reference

12 December 2020

The immune response to Leishmania: mechanisms of parasite control and evasion.

1 reference

12 December 2020

Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation.

1 reference

12 December 2020

Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.

1 reference

12 December 2020

Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?

1 reference

12 December 2020

Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy.

1 reference

12 December 2020

Type 1 and type 2 responses to Leishmania major

1 reference

12 December 2020

Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis

1 reference

12 December 2020

American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?

1 reference

12 December 2020

Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania

1 reference

12 December 2020

Second-generation vaccines against leishmaniasis

1 reference

12 December 2020

[American cutaneous leishmaniasis]

1 reference

12 December 2020

A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)

1 reference

12 December 2020

Cutaneous leishmaniasis in the Metropolitan Region of Belo Horizonte: clinical, laboratorial, therapeutic and prognosis features (1989-1995)

1 reference

12 December 2020

Immunologic memory in cutaneous leishmaniasis

1 reference

12 December 2020

In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes

1 reference

12 December 2020

Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis

1 reference

12 December 2020

Cytokine profile and pathology in human leishmaniasis

1 reference

12 December 2020

Immunologic patterns associated with cure in human American cutaneous leishmaniasis

1 reference

12 December 2020

T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure

1 reference

12 December 2020

T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy

1 reference

12 December 2020

Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis

1 reference

12 December 2020

Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment

1 reference

12 December 2020

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

12 December 2020

Leishmania (Viannia) braziliensis is the predominant species infecting patients with American cutaneous leishmaniasis in the State of Minas Gerais, Southeast Brazil

1 reference

12 December 2020

Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases

1 reference

12 December 2020

Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients

1 reference

12 December 2020

Parasitological and immunological follow-up of American tegumentary leishmaniasis patients.

1 reference

12 December 2020

Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.

1 reference

12 December 2020

The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.

1 reference

12 December 2020

Identifiers

DOI

10.1002/JCLA.20291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6649044&resulttype=core&format=json

15 May 2020

1 reference